News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
Market overviews
Direct comparison of products for laboratory and process: Use the comprehensive market overviews to compare products according to your requirements and obtain further information from suppliers.
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
11-May-2005 - Binding gold nanoparticles to a specific antibody for cancer cells could make cancer detection much easier, suggests research at the Georgia Institute of Technology and the University of California at San Francisco (UCSF). The report is published online as an ASAP article in the journal Nano ...
11-May-2005 - pSivida Limited announced that it has been granted its first patent in China. This first patent grant in China is important as China has the highest incidence of primary liver cancer in the world with 345,844 cases in 2002 and is a logical target market for BrachySil(tm). The potential lower cost ...
11-May-2005 - Viragen, Inc. and Cancer Research Technology Limited (U.K.) announced a license agreement that provides Viragen with worldwide exclusive rights to commercialize the anti-CD55 antibody, which is currently in preclinical development for the treatment of a broad range of cancers. Financial terms ...
11-May-2005 - John Wiley & Sons, Inc., announced the launch of an ambitious new program to digitize back issues of all its journal holdings, dating back to the 1800s, on Wiley InterScience, its online publishing platform. Wiley's digitization of legacy content is an ongoing project designed to improve the ...
Potential therapy for up to 30 percent of human tumors
11-May-2005 - By studying mice with skin cancer, researchers at Huntsman Cancer Institute at the University of Utah discovered a way to inhibit a mutant gene found in up to 30 percent of human tumors. Called Ras, normal copies of this gene are important in cell signaling, or communication among cells. When ...
10-May-2005 - President George Bush wasn't bugged by having a slime-mold beetle named for him. In fact, he was so pleased that he telephoned former Cornell University Professor Quentin Wheeler to thank him. "He was so gracious and friendly and spent several minutes talking and said he was honored by our ...
10-May-2005 - Genzyme Corporation and Bone Care International announced that they have signed a definitive merger agreement under which Genzyme will acquire Bone Care in an all cash transaction valued at $33.00 per fully diluted share, or approximately $600 million, net of Bone Care's cash of $119 million. ...
10-May-2005 - Theragenics Corporation(R) announced the acquisition of CP Medical, a medical device company, for approximately $19,150,000 in cash and 1,885,370 shares of Theragenics'(TM) common stock valued at approximately $6,250,000, for a total purchase price of approximately $25,400,000. The $6,250,000 in ...
10-May-2005 - Definiens and Cenix BioScience announced that they have entered into a licensing and co-marketing agreement. This step represents the formalization of an ongoing and strong relationship, as the two companies have been working together for several years now. The two companies' offerings are ...
10-May-2005 - German biotech company BioVisioN AG has sold its spin-off, ImVisioN GmbH, to the Swiss based life science investment firm Nextech Venture, L.P. ImVisioN focuses on the development of novel immunotherapeutics based on its proprietary MAT (Modular-Antigen-Transport) technology to treat allergic ...
© 1997-2024 LUMITOS AG, All rights reserved